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Volume 60, Number 5 Abstracts 1409Methods: A retrospective review was performed. Preoperative and
postoperative renal function was assessed by creatinine levels and esti-
mated glomerular ﬁltration rate calculated by the Chronic Kidney Disease
Epidemiology Collaboration equation. Renal dysfunction was deﬁned as
acute kidney injury, which is deﬁned as any postoperative rise in creati-
nine levels of >44.2 mmol/L from the preoperative value, and the
requirement of hemodialysis in patients who did not require dialysis
preoperatively.
Results: During the study period, 287 patients were analyzed; 82
(29%) had OR and 205 (71%) had standard EVAR. Most of the patients
were men, with 80.5% in the OR group and 84% in the EVAR group. A
postoperative creatinine increase was observed during the follow-up in
14.6% of ORs and 4.4% of EVARs. Two patients, one each from the OR
and EVAR group, required permanent dialysis. No patients required tempo-
rary dialysis. The mean iodinated contrast volume used in the EVARs was
134.3 6 60.2 mL. The clamp position in the OR group was infrarenal in
65.9%, above one renal artery in 14.6%, above two renal arteries in
15.9%, and supraceliac in 3.7%. The renal/visceral ischemic time was 8.5
6 16.1 min.
Conclusions: After open or endovascular aortic intervention, there is
signiﬁcant percentage of patients with a decline in renal function. This is
more common in the OR group. The risk of renal impairment after aortic
intervention should be recognized and strategies used to minimize its
incidence.
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Objectives: The Royal College of Physicians and Surgeons of Canada
introduced a compulsory Maintenance of Certiﬁcation (MOC) program in
2000 based on a 5-year cycle for all specialists. Modiﬁcations to the frame-
work and credit system were introduced in 2010; the program is now in the
third cycle. The aims of this study were to identify patterns of MOC use,
compare medical with surgical specialties, and identify opportunities for
improved MOC strategies.
Methods: The 2010-2012 database was compared with 2009 data to
identify general trends. Side-to-side comparisons were done in the 2012
database to identify variations in MOC practice across the specialties of anes-
thesia, general surgery (GS), gastroenterology (GI), cardiac surgery (CS),
cardiology (C), orthopedic surgery (OS), and vascular surgery (VS).
Results: Overall participation rates remained at 85% to 91% across
specialties and in the different cycles. The overall use of group learning ac-
tivities (93%), self-learning (85%), and self-assessment (30%) showed no
change across cycles or specialties. Speciﬁc activities varied in different spe-
cialties: conferences (CS 70% to GI 85%), rounds (OS 38% to GI 55%), per-
sonal learning projects (OS 33% to GI 50%), patient safety panels (C 13% to
GI 22%), Internet search (VS 12% to C 22%), and practice audits (VS 12% to
GI 22%). There were no differences in journal reading (38%-41%) or self-
assessment program use (2%-5%). Overall, despite specialty differences,
traditional group MOC activities continue to represent the majority of
credits reported; patient safety, self-assessment program use, practice audits,
and internet-based activities were underrepresented.
Conclusions: Specialist MOC continues in traditional activities.
There are variations by specialty. Resource-intensive self-learning and prac-
tice-assessment activities are not widely used. Strategies to modify program
planning, participant orientation, and MOC expectations are required to in-
crease uptake in certain, potentially high-value MOC activities.
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Objectives: Changing population size and distribution, incidence of
disease and risk factors, and the likelihood of need for care partly deter-
mines the demands for health care in the future. The introduction ofadvanced technology, patient and society’s expectations, the growing at-
risk population, and increased recognition of risk factors have impacted
on vascular disease management. Studies in many countries predict a dra-
matic increase in the need for care for vascular issues. A “business as usual”
model predicts a large increase in the medical manpower requirements to
meet this. The aims of this study were (1) to identify the population size,
(2) link population to vascular disease data, and (3) link disease data to
resource requirements.
Methods: Population data regarding size and distribution of disease
was sourced from StatsCan 2012 census data. The epidemiology of vascular
risk factors, recognized disease, and determinants for intervention was
sourced from a variety of academic sources. Resource requirements were
inferred from the data, with sensitivity analysis applied to variable assump-
tions. Subgroup selection was applied for Ontario.
Results: Canada’s population is approximately 36 million; Ontario’s
population is 12.8 million. The population is growing at 5.8%. The vascular
target population of patients aged 55 to 80 years is growing more rapidly.
The subgroups in Ontario by 5-year cadres range from 375.000 to
850,000, with a total of 3.2 million. The prevalence of risk factors ranges
from 17% to 52%; the need for care ranges from 8% to 32%. Assuming a ra-
tio for vascular specialists (VS) of 1:100-180,000, Ontario would need 71 to
126 VS on an on-going basis. Diagnostic and interventional resources will
increase by 22% to 52% over time.
Conclusions: Increasing population, population at risk, disease prev-
alence, and triggers for intervention will lead to dramatic increases in
vascular-related resources. Changes in VS scope of practice, involvement
of other specialties, and nonphysician practitioners and changing technology
will all affect assumptions regarding manpower and other resources for the
care of vascular patients.
Author Disclosures: D. Wooster: Nothing to disclose. E. Wooster:
Nothing to disclose.
Residency Training in Venous Disease Management Fails to Address
Practice Needs
Douglas Wooster, Elizabeth Wooster, Michael Clemente. University of
Toronto and Western University, Toronto, Ontario, Canada
Objectives: Previous surveys have shown that 91% of Canadian
vascular surgeons maintain a venous management component in their prac-
tice; 53% have seen an increasing demand over the past 5 years. The spec-
trum of venous disease that is treated is wide, and vascular surgeons
recognize only a limited group of fellow specialists as expert venous practi-
tioners (41%). The aim of this study was to compare training objectives and
practice requirements to training experiences in venous disease management
in Canadian vascular training programs.
Methods: The curriculum objectives were collected from the Royal
College training guidelines and individual program outlines. A survey of
trainees and practicing vascular surgeons was done to assess the training op-
portunities and practice parameters relevant to venous management.
Results: Program objectives include training in venous disease man-
agement. However, most programs do not have speciﬁc venous rotations
or access to dedicated venous centers. Trainees are seldom exposed to pa-
tients with venous issues in the clinic, emergency care, or rounds, nor do
they attend major venous meetings. Ministry of Health and Long-Term
Care have further limited opportunities in Ontario-based programs.
Training correlates with practice better for conservative management
(78%) than speciﬁc management (sclerotherapy, 50%; foam sclerotherapy,
42%; ambulatory phlebectomy, 55%; endovenous ablation, 50%). Throm-
bolysis training approximates practice (75%-100%) but inferior vena cava ﬁl-
ter placement (34%) and venous angioplasty (22%) do not.
Conclusions: Despite the importance of venous management in prac-
tice and its inclusion in the training curricula, training generally fails to
address most venous management issues and meet practice needs.
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Objectives: Our objective was to evaluate if low ﬁbrinogen levels dur-
ing catheter-directed thrombolysis is associated with an increased risk of
bleeding.
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dergoing thrombolysis between 2005 and 2013. Patients were allocated
to the low-ﬁbrinogen group if their ﬁbrinogen level was <1.5 g/L during
treatment or to the high-ﬁbrinogen group. Demographics, bleeding compli-
cations, and technical and clinical success were statistically analyzed between
the groups.
Results: A total of 49 patients (22 arterial and 27 venous), with a
mean age of 52.0 6 18.4 years, were included. Sixteen patients were allo-
cated to the low-ﬁbrinogen group and 26 to the high-ﬁbrinogen group
(ﬁbrinogen levels were not measured in seven patients; none of these pa-
tients had any bleeding complications). Patients were signiﬁcantly younger
(41.1 6 17.3 vs 56 6 15.7 years; P ¼ .006) and had a proportionately
higher number of venous occlusive events (87.5% vs 42.6%; P ¼ .004) in
the low-ﬁbrinogen group compared with the high-ﬁbrinogen group. Other
baseline characteristics, including gender, extremities affected, prothrom-
botic risk factors, contraindications to thrombolysis, baseline ﬁbrinogen, in-
ternational normalized ratio, partial thromboplastin time, and platelets were
similar between the groups. The low-ﬁbrinogen group used a larger total
dose of tissue plasminogen activator (tPA; 40.7 6 24.6 mg vs 21.9 6
10.5 mg, P ¼ .009) and had longer duration of tPA infusion (26.8 6
12.9 hours vs 16.9 6 6.6 hours; P ¼ .010). The rates of major and minor
bleeding were not signiﬁcantly different between the low-ﬁbrinogen vs
high-ﬁbrinogen groups (2 vs 0 cases of major bleed, respectively, P ¼
.139; 1 vs 4 cases of minor bleed, respectively; P ¼ .633). Secondary out-
comes including technical and clinical success rate, in-hospital mortality,
hospital length of stay, and secondary procedures were similar between
groups.
Conclusions: A ﬁbrinogen level of <1.5 g/L during thrombolysis
was not associated with an increased risk of bleeding complications; this
was despite a larger total dose and longer duration of tPA infusion used.
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Objectives: The aim of this study was to determine the length of stay
in our cohort of patients who underwent endovascular aortic aneurysm
repair (EVAR) and to identify patient characteristics suitable for same-day
or short-term discharge. We also conducted a review of the literature exam-
ining the evidence for safety and efﬁcacy of ambulatory and short-stay
EVAR.
Methods: A retrospective analysis of consecutive patients who under-
went elective EVAR by three vascular surgeons in our institution since April
2011 until March 2013 was conducted. Patient demographics, comorbid-
ities, aneurysm anatomy, length of stay, and complications were analyzed.
The literature review identiﬁed four articles on outpatient or short-stay
EVAR.
Results: During the study period, 162 patients underwent elective
EVAR and 138 were included in the analysis (24 patients were excluded
due to insufﬁcient data, aneurysm rupture, or thoracic endovascular aortic
repair). Seven patients (5.1%) were discharged the same day (SD) of proce-
dure, 81 patients (58.7%) were discharged on postoperative day (POD) 1,
and 50 patients (36.2%) were discharged on POD2 or longer (standard
group). The standard group was signiﬁcantly older (78.44 6 8.32 years)
than the POD1 and SD groups (72.9 6 8.41 and 71.3 6 11.2, respectively;
P ¼ .0004). Mean aneurysm size was 54 6 2.98 mm for the SD group, 57
6 9.57 mm for POD1 group, and 59 6 11.29 mm for the standard group.
The 30-day mortality was zero in all three groups. The procedures in all pa-
tients (100%) in the SD group, 70 patients (86%) discharged on POD1, and
26 patients (52%) in the standard group were performed fully percutane-
ously (P < .0001). Percutaneous arterioplasty device failure, thus necessi-
tating a femoral cutdown, occurred in eight patients (9.8%) in the POD1
group and in eight patients (16%) in the standard group (P ¼ .33). All
groups had similar baseline comorbidities (hypertension, hyperlipidemia,
chronic renal failure, diabetes mellitus, chronic obstructive pulmonary dis-
ease; not signiﬁcant [NS]). Ninety-six percent of all procedures were per-
formed with a spinal anesthetic. Reasons for prolonged hospital stay
included urinary retention, postimplantation syndrome, symptomatic aneu-
rysm, or insertion of aortouniiliac stent with cross-femoral bypass. Readmis-
sion to the hospital #30 days of EVAR was zero in SD group patients, fourpatients (5%) in the POD1 group, and three patients (6%) in the standard
group (NS). The 30-day complication rate was 5% in the POD1 group
and 20% in the standard group (P ¼ .0069).
Conclusions: Discharging patients the SD overnight after elective
EVAR is feasible and safe in patients with acceptable medical risk, good
baseline functional capacity, and who have undergone uncomplicated aneu-
rysm repair. The literature shows that discharge #24 hours post-EVAR is
feasible in one-third of patients. Future prospective studies, including cost
analysis, will be undertaken to validate these encouraging data.
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Objectives: Over the last decade the use of endografts for the repair of
abdominal aortic aneurysm has steadily increased. Despite improvements in
endograft device technology, we continue to see complications that require
reintervention. Here we present a systematic literature review of the indica-
tion for late endograft explants as well as a small case series of late endograft
explants.
Methods: We conducted a retrospective case series of three endograft
explants at a single center during a 3-year period. Additionally, systematic
literature review of the PubMed database with the search terms (explant
or late conversion) and (endograft or EVAR) was undertaken, with interest
in indications for explantation and overall outcome after explantation.
Results: We present three cases of late surgical conversion after endo-
vascular aneurysm repair (EVAR) repair of abdominal aortic aneurysm: (1)
an 88-year old woman with a late type I endoleak and proximal graft migra-
tion 18 months post-EVAR; (2) a 66-year-old man with a methicillin-resis-
tant Staphylococcus aureus infected endograft 2 years post-EVAR; and (3) a
64-year-old man with an acute occlusion of his endograft 6 years post-
EVAR. A systematic review of the literature revealed 478 reported cases
of late endograft explantation. The predominant indication for explantation
was endoleak, representing 58% (n ¼ 277) of endograft explants (type I,
106; type II, 59; type III, 41; type V, 5; multiple endoleaks, 5; undeﬁned,
62). Other indications for explant included infection 21% (n ¼ 100), occlu-
sion 5.2% (n ¼ 25), aortoenteric ﬁstula 2.7% (n ¼ 13) and claudication 1%
(n ¼ 5). Of the reported cases, 11% presented as ruptured AAA. Where re-
ported, elective 30-day mortality ranged from 0% to 10%, and nonelective
30-day mortality ranged from 19% to 53%.
Conclusions: The primary reported indication for late open conver-
sion was type I endoleaks, followed closely by infection. Although these
can be technically challenging procedures, elective open conversion comes
with a low mortality rate relative to urgent procedures. Nonadherence to
manufacturers’ recommendation for endograft use and late aortic remodel-
ing could explain large number of endoleaks noted.
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Objectives: Prosthetic vascular infection is an uncommon but devas-
tating event, occurring after w <0.1% to 5% of operations and developing
months to years after the initial implantation. Similarly, mycotic aneurysms
occur rarely but still carry a 25% mortality rate. Both entities may be chal-
lenging to eradicate. Therapeutic options are limited. Complex surgical pro-
cedures with wide debridement are often required, and outcomes are
variable. This study evaluated the use of in situ reconstruction with
custom-made bovine pericardial grafts as an alternative to in situ autologous
vein graft, prosthetic grafts, and cryopreserved arterial homografts for the
treatment of aortic graft infections and infected aortic aneurysms.
Methods: Between 2009 and 2014, eight patients (50% men; age
range, 51-84 years) with prosthetic graft infection (n ¼ 6) or thoracoabdo-
minal mycotic aneurysm (n ¼ 2) were treated with complete prosthesis or
aneurysm resection, together with wide local debridement and arterial
